Beam Therapeutics Stock Forward View - 4 Period Moving Average

BEAM Stock

USD 32.32 0.85 2.70%

4 Period Moving Average is applied to Beam Therapeutics's daily closing prices, and the resulting forecast is presented with accuracy metrics. Wide deviation between fitted and observed values suggests the model's assumptions may not match current market conditions. The 4 Period Moving Average model projects Beam Therapeutics at 32.11 for the next trading day, below the most recent closing price. This 4 Period Moving Average output is provided as analytical reference and does not constitute a trading recommendation.

The four-period moving average forecast for Beam Therapeutics replaces each daily value with the mean of that value and the four preceding closing prices. This smoothing window is wide enough to dampen short-term noise while still responding to recent price shifts in Beam Therapeutics.

4 Period Moving Average Price Forecast For the 11th of May 2026

Over a 90-day horizon, the 4 Period Moving Average model forecasts Beam Therapeutics at 32.11 for the next trading day, with a mean absolute deviation of 1.16 , mean absolute percentage error of 0.04 , and sum of absolute errors of 66.13 .

This represents a tight forecast with good short-term tracking of Beam Therapeutics' price movement. This output is intended for short-term analytical reference.

Stock Forecast Pattern

Backtest Beam Therapeutics

Beam Therapeutics Price Prediction

Research Analysis

Forecasted Value

This forecast for Beam Therapeutics frames the expected trading range using downside and upside bounds rather than a single point target. The model places downside around 27.69 and upside around 36.53 for the next session. The wide range indicates elevated uncertainty in short-term projections.

Market Value

32.32

27.69

Downside

32.11

Expected Value

36.53

Upside

Target Odds

Above Odds

Below Odds

Model Predictive Factors

The table below summarizes the 4 Period Moving Average model's error metrics for Beam Therapeutics stock. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.

AIC	Akaike Information Criteria	111.5712
Bias	Arithmetic mean of the errors	-0.2019
MAD	Mean absolute deviation	1.1601
MAPE	Mean absolute percentage error	0.0418
SAE	Sum of the absolute errors	66.125

The model is suited for higher-volatility price series where a two-period average would be too reactive. It does not extrapolate a trend equation, so its forecasting utility is limited to one or two periods ahead. Tighter error metrics (lower MAD/MAPE) indicate that Beam Therapeutics price movement is well-captured by this smoothing window.

Other Forecasting Options for Beam Therapeutics

Beam Therapeutics' daily price returns decompose into trend, seasonal, and residual components. Divergence between short-term and long-term averages in Beam often signals an upcoming reversal or acceleration.

Beam Therapeutics Related Equities

These stocks within the Health Care space are often compared to Beam Therapeutics by analysts and fund managers in the sector. Key comparison metrics include price-to-earnings, profit margin, and revenue growth across Beam Therapeutics' peer group. A stock that beats its peers on many metrics often deserves a closer look from value-focused investors.

Agios Pharm Denali Therapeutics Recursion Pharmaceuticals Immunitybio Arcus Biosciences 89bio Inc Cogent Biosciences Mineralys Therapeutics Common Ideaya Biosciences Galapagos NV ADR American Airlines Group Alcoa Corp Apple Inc Best Buy Co Citigroup

Risk & Return

Correlation

Beam Therapeutics Market Strength Events

Market strength indicators for Beam Therapeutics stock provide a framework for assessing security responsiveness. A rising Accumulation/Distribution line alongside rising price confirms institutional buying interest in Beam Therapeutics.

	Accumulation Distribution	0.048
	Daily Balance Of Power	0.5449
	Rate Of Daily Change	1.03
	Day Median Price	31.69
	Day Typical Price	31.9
	Market Facilitation Index	1.56
	Price Action Indicator	1.06
	Period Momentum Indicator	0.85

Beam Therapeutics Risk Indicators

Assessing Beam Therapeutics' risk indicators is a structured way to evaluate the risk-return trade-off for beam stock. The level of risk embedded in Beam Therapeutics' feeds directly into exposure calibration.

	Mean Deviation	3.46
	Semi Deviation	4.03
	Standard Deviation	4.57
	Variance	20.87
	Downside Variance	18.35
	Semi Variance	16.24
	Expected Short fall	-3.73

Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Beam Therapeutics Short Properties

Short-interest data for Beam Therapeutics reveals whether bearish conviction in the market is gaining traction. A disciplined short-interest review can make timing decisions more informed under rising skepticism.

	Common Stock Shares Outstanding	98.91 million
	Cash And Short Term Investments	1.25 billion

	Naive Prediction
	Simple Exponential Smoothing
	Double Exponential Smoothing
	Triple Exponential Smoothing
	Simple Regression
	Polynomial Regression
	Simple Moving Average
	4 Period Moving Average
	8 Period Moving Average
	20 Period Moving Average